These Subtle Signs Reveal Impending Cardiac Arrest

James Gandolfini
James Gandolfini (Photo credit: Wikipedia)
The Sopranos star James Gandolfini might have been saved if he had recognized any of the symptoms that can warn of a cardiac arrest up to a month ahead of time, a top cardiologist tells Newsmax Health.
 
“There are warning signs that often precede sudden cardiac arrest, but the problem is that people don’t recognize them,” says Chauncey Crandall, M.D., director of preventative medicine and clinical cardiology at the Palm Beach Cardiovascular Clinic. “James Gandolfini and hundreds of thousands of other heart victims like him could have been saved.”
 
Editor's Note: Top Cardiologist Discovers 'Simple Heart Cure'
 
Gandolfini died of sudden cardiac arrest last June at age 51 while he was vacationing in Rome with his family. Although his death seemed to strike without warning, that was probably not the case, Dr. Crandall says.
 
“Asymptomatic cardiac death is pretty rare. When you go back and talk to those who survive it, or their families, you’ll find that there is always something that provides an indication that something was wrong before the attack,” he says.
 
“The symptom could be chest pain, even very minor – or shoulder pain, neck pain, back pain, or episodes of nausea. Perhaps their blood pressure was suddenly elevated. All these things can indicate that a heart attack is going to happen or is happening.”
 
Warning signs may be even subtler. “Perhaps their color is off, they feel dizzy, they are short of breath, they fainted, or they are extremely fatigued – all these things can be telltale warning signs,” says Dr. Crandall, author of the No. 1 Amazon best-selling book The Simple Heart Cure: The 90-Day Program to Stop and Reverse Heart Disease.
 
About 325,000 people die from sudden cardiac death each year, many of them, like Gandolfini, middle-aged men. It is the largest cause of death in the U.S.
 
Sudden cardiac death occurs when the heart suddenly ceases to beat, usually because the heartbeat is irregular and dangerously fast. 

Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Headline/subtle-signs-impending-heart-attack/2013/12/03/id/539641#ixzz2mVg3gpbk
Alert: What Is Your Risk for a Heart Attack? Find Out Now
Enhanced by Zemanta

Breakthrough Hormone Treatment Fights Parkinson's

Parkinson's Disease Cure
Parkinson's Disease Cure (Photo credit: Elva Keaton)
Developed by Scottsdale physician Gino Tutera, M.D., the therapy uses bio-identical hormones, delivered through implants placed under the skin, to ease the symptoms of Parkinson's and slow its progression.
 
Since starting treatment, Puzzi tells Newsmax Health, his health and psychological outlook have improved dramatically and his symptoms are largely under control.
 
"It was just an unbelievable change in my life," says Puzzi, of the impact of the therapy. "I've cut my medicine down from eight pills a day to four pills a day. It made a world of difference in my quality of life and everything in my world today. I wouldn't know what to do without the pellets."
 
Story continues below video.

Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Health-News/breakthrough-hormone-treatment-sottopelle/2013/11/29/id/539172#ixzz2mEnryXKl
Alert: What Is Your Risk for a Heart Attack? Find Out Now
Enhanced by Zemanta

How a man's sex drive is linked to a breast milk hormone

Men who lack desire have low levels of it, study finds

  • Men with lower levels of prolactin had worse health both sexually and overall
  • Prolactin is best known for its role as the hormone that stimulates breast development and milk production in women
  • But it has many other functions and has been linked with sexual satisfaction
Men with a poor sex drive may have low levels of a hormone traditionally associated with breastfeeding.
A study has found that men with reduced levels of prolactin had worse health both sexually and overall.
Prolactin is a hormone produced by the pituitary gland, which lies under the brain. It is best known for its role as the hormone that stimulates breast development and milk production in women.
Worried: Men with a poor sex drive may have low levels of the hormone prolactin, a new study has found
Worried: Men with a poor sex drive may have low levels of the hormone prolactin, a new study has found



But it also has many other functions, including providing the body with sexual satisfaction. The hormone is thought to counteract the effect of dopamine, which is responsible for sexual desire.

Until now, it was thought that high levels it affected a man's performance in the bedroom, so the researchers say they were surprised by the new findings.
Enhanced by Zemanta

The female Viagra: Could this 'miracle gel' restore women's sex drive in just TWO WEEKS?

I get dozens of emails every day from woman desperate for tips on how to get their sex drives back.

What if I told you simply rubbing a gel onto your thighs or arms could get it back in two weeks?

I’ve seen this gel dramatically increase the sex drive of several women I know - with startling results - yet hardly anyone knows about it.

Testosterone gels, available on the NHS and privately, boost the level of the hormone which plays a role in our sex drive.
Sexpert: Sex should be about trying to feel good not look good says Tracey
Tracey says there's an advantage to a slightly dampened libido - you're less likely to cheat
We think of testosterone as a male hormone (produced in the testicles) but women also produce it (in the ovaries) in lesser quantities.

If your testosterone level is low - which can happen pre-menopause, as well as after because the levels fall as age - the urge for sex decreases substantially.
Replace what your body isn’t producing anymore and you could find your sex drive is back to what it was in your 30s.
Enhanced by Zemanta

New heart disease guidelines called into question

The nation's first new guidelines in a decade for preventing heart attacks and strokes call for twice as many Americans - one-third of all adults - to consider taking cholesterol-lowering statin drugs. They use a new formula for estimating someone's risk that includes many factors besides cholesterol, the main focus now. Above, Atorvastatin Calcium tablets, a generic form of Lipitor.


Enhanced by Zemanta

Cure for Celiac Coming?

 PICTURE:   Dr. Alessio Fasano, Victoria Kennedy, Dr. Ronald Kleinman, and Dr. Peter Slavin have their picture taken by a Mass. General staff photographer at the Museum of Medical History and Innovation.


When Leslie Williams, a former pharmaceutical executive, agreed to meet a visiting professor from Australia in Boston for a lecture, she thought it would be a routine lunch in her role as a business mentor.

But the meeting, three years ago at the Boston Cambridge Marriott, turned into an intense five-hour discussion as Dr. Robert Anderson explained how his research into celiac disease promised to render the destructive disorder obsolete.

An autoimmune disease triggered by gluten proteins in wheat, barley, and rye, celiac disease affects­ some 3 million Americans. Untreated, it can destroy digestive tract tissue and can lead to anemia, osteoporosis, infertility, neurological dysfunction, or even cancer.

Currently, the only solution is to avoid gluten altogether. That means not eating standard versions of bread, pasta, and pizza, or anything else that contains even traces of wheat, including soy sauce and some candy, such as Twizzlers.

Dr. Robert Anderson’s research is zeroing in on a potential vaccine against celiac disease.
Dr. Robert Anderson’s research is zeroing in on a potential vaccine against celiac disease.


But as Anderson explained that afternoon to Williams, his research was zeroing in on a vaccine to cure celiac disease.

The science “struck me as quite special and possibly­ game-changing,” Williams recalled.
She agreed to work with Anderson, and in short order Williams lined up seed capital from an angel investor and then went to Australia to unravel legal­ agreements around Anderson’s research and his company. Within the year, ImmusanT was formed, with Williams as chief executive and Anderson­ as chief scientific officer. By its first ­anniversary, the firm had $20 million in venture funding.

ImmusanT is headquartered in the biotech boomtown of Kendall Square in Cambridge and is conducting clinical trials for its vaccine, NexVax2, under “fast-track” designation from the Food and Drug Administration for diseases for which no comparable therapies exist.

“If it works, you’ll see the entire paradigm of treatment for celiac changed,” said Sundar Kodiyalam, managing director for the venture investor Vatera Healthcare and an ImmusanT board member. His firm was so enamored of the science that it invested before the company had persuasive clinical data.
Beyond ImmusanT, Boston has become a locus for research into celiac disease. Massachusetts General Hospital scored a coup when it recently convinced a leading researcher, Dr. Alessio Fasano, to head its new celiac treatment and research center. “Our mission is to make life normal for people with celiac disease,” Fasano said at a ceremony marking the opening of the Mass. General center in February.

With similar research units at Beth Israel Deaconess Medical Center and Children’s Hospital Boston, the city now has “a critical mass of expertise” in celiac disease, said Dr. Ronald Kleinman, physician in chief of Mass. General’s pediatric unit.

“I’m not sure that I see miracles happening” with the research underway now, said Lee Graham, chairwoman of Healthy Villi, a 900-member support group for celiac sufferers in New England. “But the gathering that’s happening in Boston is terrific, and tremendously encouraging to us.”
Formerly at the University of Maryland, Fasano in 2003 published a landmark analysis in which he determined that celiac disease affects many more people than previously thought: about 1 out of 100 people. Up to that point, the scientific wisdom was that celiac was relatively rare, and that a gluten-free diet worked as a sufficient “cure.”

But Fasano and others have since shown that some patients who avoid gluten continue to suffer gastric distress, leading to the conclusion that diet alone is not enough.
Not surprisingly, with the market for gluten-free foods at $4.2 billion, ImmunsanT has some company in the race for a solution.

Read the rest of the story HERE

Enhanced by Zemanta

Superfish (Not Just Salmon) You Should Be Eating

Superfish (Not Just Salmon) You Should Be Eating
Just about every nutrition expert recommends eating lots of fish - at least once a week, preferably more often. The fish most often cited to reduce risk of heart disease, cancer, Alzheimer's, and diabetes is wild salmon. However, wild salmon is expensive, sometimes... [Full Story]

Read Latest Breaking News from Newsmax.com http://www.newsmax.com/#ixzz2kOVvUets
Urgent: Should Obamacare Be Repealed? Vote Here Now!
Enhanced by Zemanta

Anti-Testosterone Study Is Misleading, Overhyped: Top Doctor

Chemical Structure of Testosterone.
Chemical Structure of Testosterone. (Photo credit: Wikipedia)
A new headline-making study warning of dire side effects from testosterone medications is misleading and has been overhyped, says a top hormone therapy expert.
 
“I’m concerned that men will stop taking testosterone because of this new study,” Erika Schwartz, M.D., told Newsmax Health. “It contradicts all the previous research that shows the benefits of this form of therapy. When taken properly, the results of testosterone therapy can be amazing.”
 
Editor's Note: Video Exposes Dangers of Obamacare Law

The new research suggests that men who take testosterone after undergoing a minor cardiac procedure are more likely to suffer strokes, heart attacks, or die. The study was published in the Journal of the American Medical Association. The  findings directly contradict a similar study done last year, which found that similarly aged men who took testosterone had a 50 percent less risk of dying, noted Dr. Schwartz, a leading national expert who has hosted a PBS special on hormone therapies.
 
The major difference between the two studies was the condition of the subjects. Most of the men in the new study had serious health problems, including a prior history of heart attack, congestive heart failure, or confirmed coronary heart disease. Men in the previous study were healthier.
 
“All this study showed was that older men with heart disease, who are sick, are not likely to benefit from starting testosterone therapy. It says nothing about the relatively healthy men who have benefited from testosterone therapy and use it for prevention,” said Dr. Schwartz. “My patients, if they start testosterone early enough, they benefit tremendously.”
 

Read Latest Breaking News from Newsmax.com http://www.newsmaxhealth.com/Headline/testosterone-low-t-aging-dangers/2013/11/07/id/535445#ixzz2k3jjP5a8
Alert: What Is Your Risk for a Heart Attack? Find Out Now
Enhanced by Zemanta